Steve Schonfeld’s Apogee Therapeutics APGE Stock Holding History
Bought
Maintained
Sold
Other funds holding APGE
Steve Schonfeld's APGE Position: Q3 2026 in Review
Steve Schonfeld sold out of Apogee Therapeutics (APGE) in Q3 2026, closing a stake of 31,059 shares — an estimated $4.12M sold.
Steve Schonfeld first reported a position in APGE in Q4 2024 and held it in 4 quarters. The position peaked at $4.12M in Q2 2026. 2 funds tracked by Wall St. Rank hold APGE as of Q3 2026.
- Steve Schonfeld reported no remaining Apogee Therapeutics position as of Q3 2026 after selling out during the quarter.
- Steve Schonfeld sold 31,059 Apogee Therapeutics shares in Q3 2026, an estimated $4.12M.
- Steve Schonfeld first reported a position in Apogee Therapeutics in Q4 2024 and held it in 4 quarters.
- Steve Schonfeld's Apogee Therapeutics position peaked at $4.12M in Q2 2026.
- 2 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q3 2026.
Based on Schonfeld Strategic Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.